K-numberK243684
Device nameBrightHeart View Classifier
ApplicantBrightheart
Product codeQIH
Device classClass II
Decision dateMay 7, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

BrightHeart View Classifier is a cloud-based software device using machine learning to automatically detect and classify standard fetal heart views in 2D ultrasound images and video clips. It is intended for use by qualified healthcare professionals (sonographers, MFMs, OB/GYNs, fetal surgeons) as an adjunct to fetal anatomic ultrasound examination acquisition and interpretation during the second or third trimester of pregnancy.

Technological characteristics

Both the subject device and predicate (Sonix Health) are Software as a Medical Device (SaMD) applications using trained neural networks to identify standard cardiac views from ultrasound images and video clips. The key difference is that BrightHeart View Classifier is trained on fetal ultrasounds, while Sonix Health uses adult echocardiograms. BrightHeart includes a Predetermined Change Control Plan; Sonix Health does not. Sonix Health includes measurement functionality not present in BrightHeart View Classifier.

Test standards cited

IEC 62304:2016 (Medical device software — Software life cycle processes); FDA Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices; FDA Guidance on Content of Premarket Submissions for Management of Cybersecurity in Medical Devices.

Substantial equivalence argument

Both devices share the same fundamental purpose and technological approach: using trained neural networks to classify standard cardiac views in ultrasound imaging as an adjunct to clinician decision-making. Although BrightHeart targets fetal ultrasound while Sonix Health targets adult echocardiography, this difference in application domain does not raise different safety or effectiveness questions because both devices perform the same core function—automated view classification. The Sonix measurement functionality (absent in BrightHeart) removes a potential difference. Performance testing demonstrated BrightHeart achieves sensitivity of 0.939 and specificity of 0.984 with consistent performance across demographic subgroups and ultrasound vendors tested.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →